Janssens Pleun, Koenraadt-van Oost Iris, van Boekel Leonieke, Eygendaal Denise, Beumer Annechien, van der Velden Miriam, The Bertram
Department of Orthopedic Surgery, Amphia Hospital, Breda, Netherlands.
Foundation for Orthopedic Research, Care & Education, Amphia Hospital, Breda, Netherlands.
Anesth Pain Med. 2024 Aug 31;14(4):e146816. doi: 10.5812/aapm-146816. eCollection 2024 Aug.
Non-invasive treatment options are preferred for managing upper extremity pain due to osteoarthritis (OA). Transcutaneous pulsed radiofrequency (TcPRF) is a promising technique and appears effective in managing knee and shoulder pain.
To investigate whether TcPRF treatment is effective in reducing pain and safe to use among patients with OA of the upper extremity.
In this retrospective study, patients with painful OA of the upper extremity who underwent TcPRF treatment from February 2021 to February 2022 were included. The primary outcome measure was the change in NRS pain scores between baseline and 1, 2, and 6 weeks of follow-up. Secondary outcome measures included adverse events. Data were extracted from electronic medical records and via telephone consultation after the 6-week follow-up.
A total of 41 initial TcPRF treatments were performed among 37 patients. The NRS score at rest showed a statistically significant improvement at 6 weeks [median = 5 [interquartile range (IQR) 2 - 8)] compared with baseline [median = 6 (IQR 4 - 8)], P = 0.023, with a moderate effect size, r = -0.44. For NRS scores during activity, all follow-up moments had lower NRS scores [median = 7 (IQR 5 - 8)] than before TcPRF [median = 8 (IQR 7 - 9)], P = 0.002 - 0.006, with moderate to large effect sizes, r = -0.45 to r = -0.51. No adverse events were reported.
Transcutaneous pulsed radiofrequency treatment is effective in reducing pain and is safe to use among patients with upper extremity pain due to OA.
对于骨关节炎（OA）所致的上肢疼痛，非侵入性治疗方案是首选。经皮脉冲射频（TcPRF）是一种有前景的技术，在治疗膝关节和肩部疼痛方面似乎有效。
探讨经皮脉冲射频治疗对减轻上肢骨关节炎患者疼痛是否有效以及使用是否安全。
在这项回顾性研究中，纳入了2021年2月至2022年2月接受经皮脉冲射频治疗的上肢疼痛性骨关节炎患者。主要结局指标是基线与随访1周、2周和6周时数字评定量表（NRS）疼痛评分的变化。次要结局指标包括不良事件。数据从电子病历中提取，并在6周随访后通过电话咨询获取。
37例患者共进行了41次初次经皮脉冲射频治疗。静息时的NRS评分在6周时[中位数 = 5（四分位间距（IQR）2 - 8）]较基线[中位数 = 6（IQR 4 - 8）]有统计学显著改善，P = 0.023，效应量中等，r = -0.44。对于活动时的NRS评分，所有随访时间点的NRS评分[中位数 = 7（IQR 5 - 8）]均低于经皮脉冲射频治疗前[中位数 = 8（IQR 7 - 9）]，P = 0.002 - 0.006，效应量中等至大，r = -0.45至r = -0.51。未报告不良事件。
经皮脉冲射频治疗在减轻因骨关节炎所致上肢疼痛的患者疼痛方面有效且使用安全。
